Patents by Inventor Anders Brandt

Anders Brandt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11739140
    Abstract: The present invention relates to a novel class of monoclonal antibody that specifically binds the phosphorylated serine 396 residue on pathological hyperphosphorylated (PHF) tau (pS396), as well as to methods of using these molecules and their tau binding fragments in the treatment of Alzheimer's disease and tauopathies.
    Type: Grant
    Filed: January 8, 2021
    Date of Patent: August 29, 2023
    Assignee: H. Lundbeck A/S
    Inventors: Jan Torleif Pedersen, Lars Østergaard Pedersen, Justus Claus Alfred Daechsel, Ayodeji Abdur-rasheed Asuni, Nina Helen Rosenqvist, Christiane Volbracht, Lone Helboe, Anders Brandt Elvang, Florence Sotty, Søren Christensen, Jeffrey B. Stavenhagen
  • Publication number: 20210206843
    Abstract: The present invention relates to a novel class of monoclonal antibody that specifically binds the phosphorylated serine 396 residue on pathological hyperphosphorylated (PHF) tau (pS396), as well as to methods of using these molecules and their tau binding fragments in the treatment of Alzheimer's disease and tauopathies.
    Type: Application
    Filed: January 8, 2021
    Publication date: July 8, 2021
    Applicant: H. Lundbeck A/S
    Inventors: Jan Torleif Pedersen, Lars Østergaard Pedersen, Justus Claus Alfred Daechsel, Ayodeji Abdur-rasheed Asuni, Nina Helen Rosenqvist, Christiane Volbracht, Lone Helboe, Anders Brandt, Florence Sotty, Søren Christensen, Jeffrey B. Stavenhagen
  • Patent number: 10934348
    Abstract: The present invention relates to a novel class of monoclonal antibody that specifically binds the phosphorylated serine 396 residue on pathological hyperphosphorylated (PHF) tau (pS396), as well as to methods of using these molecules and their tau binding fragments in the treatment of Alzheimer's disease and tauopathies.
    Type: Grant
    Filed: December 20, 2019
    Date of Patent: March 2, 2021
    Assignee: H. Lundbeck A/S
    Inventors: Jan Torleif Pedersen, Lars Østergaard Pedersen, Justus Claus Alfred Daechsel, Ayodeji Abdur-rasheed Asuni, Nina Helen Rosenqvist, Christiane Volbracht, Lone Helboe, Anders Brandt Elvang, Florence Sotty, Søren Christensen, Jeffrey B. Stavenhagen
  • Publication number: 20200190178
    Abstract: The present invention relates to a novel class of monoclonal antibody that specifically binds the phosphorylated serine 396 residue on pathological hyperphosphorylated (PHF) tau (pS396), as well as to methods of using these molecules and their tau binding fragments in the treatment of Alzheimer's disease and tauopathies.
    Type: Application
    Filed: December 20, 2019
    Publication date: June 18, 2020
    Inventors: Jan Torleif Pedersen, Lars Østergaard Pedersen, Justus Claus Alfred Daechsel, Ayodeji Abdur-rasheed Asuni, Nina Helen Rosenqvist, Christiane Volbracht, Lone Helboe, Anders Brandt Elvang, Florence Sotty, Søren Christensen, Jeffrey B. Stavenhagen
  • Patent number: 10562962
    Abstract: The present invention relates to a novel class of monoclonal antibody that specifically binds the phosphorylated serine 396 residue on pathological hyperphosphorylated (PHF) tau (pS396), as well as to methods of using these molecules and their tau binding fragments in the treatment of Alzheimer's disease and tauopathies.
    Type: Grant
    Filed: November 13, 2018
    Date of Patent: February 18, 2020
    Assignee: H. Lundbeck A/S
    Inventors: Jan Torleif Pedersen, Lars Østergaard Pedersen, Justus Claus Daechsel, Ayodeji Abdur-rasheed Asuni, Nina Helen Rosenqvist, Christiane Volbracht, Lone Helboe, Anders Brandt Elvang, Florence Sotty, Søren Christensen, Jeffrey B. Stavenhagen
  • Publication number: 20190177401
    Abstract: The present invention relates to a novel class of monoclonal antibody that specifically binds the phosphorylated serine 396 residue on pathological hyperphosphorylated (PHF) tau (pS396), as well as to methods of using these molecules and their tau binding fragments in the treatment of Alzheimer's disease and tauopathies.
    Type: Application
    Filed: November 13, 2018
    Publication date: June 13, 2019
    Inventors: Jan Torleif Pedersen, Lars Østergaard Pedersen, Justus Claus Daechsel, Ayodeji Abdur-rasheed Asuni, Nina Helen Rosenqvist, Christiane Volbracht, Lone Helboe, Anders Brandt Elvang, Florence Sotty, Søren Christensen, Jeffrey B. Stavenhagen
  • Patent number: 10277519
    Abstract: Networks with a plurality of independent nodes are useful when the nodes can communicate with one another and with nodes and resources outside the network. The present disclosure addresses ways to encapsulate packets as they move from a sender to a receiver, and also addresses ways for speeding up messages between nodes by orderly queuing and processing of messages. The present disclosure also includes techniques for mapping nodes in a home area network to IP addresses in a local area network.
    Type: Grant
    Filed: January 9, 2015
    Date of Patent: April 30, 2019
    Assignee: Silicon Laboratories Inc.
    Inventors: Anders Brandt, Anders Esbensen, Jakob Buron, Jonas Roum-Møller
  • Patent number: 10196439
    Abstract: The present invention relates to a novel class of monoclonal antibody that specifically binds the phosphorylated serine 396 residue on pathological hyperphosphorylated (PHF) tau (pS396), as well as to methods of using these molecules and their tau binding fragments in the treatment of Alzheimer's disease and tauopathies.
    Type: Grant
    Filed: July 12, 2016
    Date of Patent: February 5, 2019
    Assignee: H. Lundbeck A/S
    Inventors: Jan Torleif Pedersen, Lars Østergaard Pedersen, Justus Claus Alfred Daechsel, Ayodeji Abdur-Rasheed Asuni, Nina Helen Rosenqvist, Christiane Volbracht, Lone Helboe, Anders Brandt Elvang, Florence Sotty, Søren Christensen, Jeffrey B. Stavenhagen
  • Publication number: 20150142945
    Abstract: Networks with a plurality of independent nodes are useful when the nodes can communicate with one another and with nodes and resources outside the network. The present disclosure addresses ways to encapsulate packets as they move from a sender to a receiver, and also addresses ways for speeding up messages between nodes by orderly queuing and processing of messages. The present disclosure also includes techniques for mapping nodes in a home area network to IP addresses in a local area network.
    Type: Application
    Filed: January 9, 2015
    Publication date: May 21, 2015
    Inventors: Anders Brandt, Anders Esbensen, Jakob Buron, Jonas Roum-Møller
  • Publication number: 20150131485
    Abstract: Networks with a plurality of independent nodes are useful when the nodes can communicate with one another and with nodes and resources outside the network. The present disclosure addresses ways to encapsulate packets as they move from a sender to a receiver, and also addresses ways for speeding up messages between nodes by orderly queuing and processing of messages. The present disclosure also includes techniques for mapping nodes in a home area network to IP addresses in a local area network.
    Type: Application
    Filed: January 9, 2015
    Publication date: May 14, 2015
    Inventors: Anders Brandt, Anders Esbensen, Jakob Buron, Jonas Roum-Møller
  • Publication number: 20150117462
    Abstract: Networks with a plurality of independent nodes are useful when the nodes can communicate with one another and with nodes and resources outside the network. The present disclosure addresses ways to encapsulate packets as they move from a sender to a receiver, and also addresses ways for speeding up messages between nodes by orderly queuing and processing of messages. The present disclosure also includes techniques for mapping nodes in a home area network to IP addresses in a local area network.
    Type: Application
    Filed: January 9, 2015
    Publication date: April 30, 2015
    Inventors: Anders Brandt, Anders Esbensen, Jakob Buron, Jonas Roum-Møller